Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Editas Medicine (EDIT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Editas Medicine (EDIT) Looks Good: Stock Moves Up 11.3%

Editas Medicine, Inc. (EDIT) moved big moved last session, as its shares rose over 11% on the day.

EDIT : 19.49 (-6.03%)
ALXN : 136.47 (-0.06%)
BUYINS.NET: EDIT SqueezeTrigger Price is $20.72. There is $117,581,437 That Short Sellers Still Need To Cover.

BUYINS.NET / www.buyins.net is monitoring Editas Medicine Inc. (NASDAQ:EDIT) in real time and just received an alert that EDIT is crossing above its primary SqueezeTrigger Price, the price that a short...

EDIT : 19.49 (-6.03%)
Editas Medicine Announces Second Quarter 2017 Results and Update

Leber Congenital Amaurosis type 10 (LCA10) product candidate EDIT-101 made significant progress toward clinical trials

EDIT : 19.49 (-6.03%)
J.P. Morgan Vice Chairman Stephen Berenson Joins Flagship Pioneering

Flagship Pioneering, a fully-integrated life science innovation enterprise, today announced that Stephen Berenson has joined the firm as executive partner. The former vice chairman of investment banking...

SYRS : 20.66 (-1.29%)
AGIO : 55.99 (-0.41%)
MCRB : 13.56 (+0.44%)
JPM : 91.77 (-0.35%)
EDIT : 19.49 (-6.03%)
Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Editas Medicine

NEW YORK, NY / ACCESSWIRE / May 31, 2017 / Editas Medicine's shares plunged yesterday after a published paper in the scientific journal Nature Methods revealed that the genome editing tool CRISPR/Cas9,...

EDIT : 19.49 (-6.03%)
VRX : 14.63 (+3.39%)
What's in Store for Merck KGaA (MKGAF) in Q1 Earnings?

Merck KGaA (MKGAF) is scheduled to report first-quarter 2017 earnings results on May 18.

AZN : 29.36 (+0.62%)
EDIT : 19.49 (-6.03%)
PFE : 33.31 (-0.15%)
MKGAF : 108.7599 (+0.33%)
Why Editas Medicine (EDIT) Might Surprise This Earnings Season

Investors are always looking for stocks that are poised to beat at earnings season and Editas Medicine, Inc. (EDIT) may be one such company.

EDIT : 19.49 (-6.03%)
Editas Medicine Announces Pre-Clinical Data for Program to Treat Sickle Cell Disease and Beta-Thalassemia

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from its pre-clinical hematopoietic stem cell (HSC) program confirming the potential for CRISPR-based editing...

EDIT : 19.49 (-6.03%)
Perrigo Company (PRGO) Q1 Earnings: Disappointment in Store?

Perrigo Company plc (PRGO) is expected to report first-quarter 2017 results later this month.

AUPH : 6.26 (+0.48%)
CDTX : 6.40 (+10.34%)
EDIT : 19.49 (-6.03%)
PRGO : 79.27 (+0.11%)
4 Drug Stocks Poised to Beat this Earnings Season

M&A and licensing deals as well as drug pricing issues are expected to remain in focus in 2017.

ENDP : 8.87 (+1.95%)
JNJ : 133.51 (-0.49%)
IMDZ : 8.35 (unch)
LLY : 78.64 (-2.54%)
IONS : 48.49 (+2.28%)
EDIT : 19.49 (-6.03%)
GILD : 72.59 (-1.04%)
BIIB : 290.31 (-1.28%)
Editas Medicine to Present at Investor Conferences in May

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in May. Details are as follows:

EDIT : 19.49 (-6.03%)
Editas Medicine to Host Conference Call Discussing First Quarter 2017 Corporate Update and Results

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Monday, May 15, 2017, at 5:00 p.m. ET to discuss a corporate update...

EDIT : 19.49 (-6.03%)
What's in Store for Immune Design (IMDZ) Stock in Q1 Earnings?

Immune Design Corp (IMDZ) is expected to report first-quarter 2017 results on May 9.

IMDZ : 8.35 (unch)
IONS : 48.49 (+2.28%)
EDIT : 19.49 (-6.03%)
RHHBY : 31.6650 (+0.40%)
What's in Store for BioDelivery (BDSI) this Earnings Season?

BioDelivery Sciences International, Inc. (BDSI) is expected to report first-quarter 2017 results later this month. Last quarter, the company???s loss was wider than expected.

ENDP : 8.87 (+1.95%)
BDSI : 3.33 (+0.91%)
CDTX : 6.40 (+10.34%)
EDIT : 19.49 (-6.03%)
Teva Pharmaceutical (TEVA) Q1 Earnings: What's in the Cards?

Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to report first-quarter 2017 earnings on May 11

MYL : 31.17 (+2.30%)
IONS : 48.49 (+2.28%)
EDIT : 19.49 (-6.03%)
TEVA : 17.53 (+0.23%)
Is Horizon Pharma (HZNP) Poised for a Beat in Q1 Earnings?

Horizon Pharma plc (HZNP) is scheduled to report first-quarter 2017 results before the opening bell on May 8.

HZNP : 12.50 (+5.13%)
IMDZ : 8.35 (unch)
EDIT : 19.49 (-6.03%)
FGEN : 40.65 (-0.25%)
What's in the Cards for Allergan (AGN) this Earnings Season?

Allergan plc (AGN) will be reporting first-quarter 2017 earnings result on May 9, before the market opens.

AGN : 227.44 (-0.24%)
IMGN : 6.20 (+1.31%)
EDIT : 19.49 (-6.03%)
FGEN : 40.65 (-0.25%)
Arena Pharmaceuticals (ARNA) Q1 Earnings: What's in Store?

Arena Pharmaceuticals, Inc. (ARNA) is expected to report first-quarter 2017 on May 9, after market closes.

ARNA : 20.75 (+0.39%)
EDIT : 19.49 (-6.03%)
FGEN : 40.65 (-0.25%)
TEVA : 17.53 (+0.23%)
Can Ligand (LGND) Spring a Surprise this Earnings Season?

Ligand Pharmaceuticals Incorporated (LGND) is scheduled to report first-quarter 2017 results on May 9, after the market closes.

LGND : 128.21 (+0.53%)
NVS : 83.75 (-0.73%)
EDIT : 19.49 (-6.03%)
FGEN : 40.65 (-0.25%)
What to Expect from Epizyme (EPZM) This Earnings Season?

Epizyme, Inc. (EPZM) is scheduled to report first-quarter 2017 results on May 8, before the opening bell.

EDIT : 19.49 (-6.03%)
FGEN : 40.65 (-0.25%)
RHHBY : 31.6650 (+0.40%)
EPZM : 14.00 (+1.08%)

Van Meerten Stock Picks

5 Mid Cap Picks
Today I wanted to find 5 Mid Cap Stocks with current momentum, so I used Barchart to sort the S&P 400 Mid Cap Index stocks first for the highest Weighted Alpha, then again for technical buy signal s of 80% or more.
CGNX -0.74 , IPGP -0.96 , NVR +0.82 , TTWO -0.48 , AAN -0.55
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Sep E-mini S&Ps ( ESU17 -0.16% ) this morning are down -0.13% and European stocks are down -0.29% as weakness in energy stocks drags the overall market lower. Sep WTI crude oil ( CLU17 -0.34% ) is down ... Read More

Chart of the Day

Chart of the Day

Health Insurance Innovations (HIIQ) is the Barchart Chart of the Day.  The health insurance company has a Trend Spotter buy signal, a Weighted Alpha of 341.00+ and gained 538.73% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures are mostly a penny higher this morning ahead of the weekly USDA Export Sales report. They ended Wednesday with most contacts 1 1/2 to 2 3/4 lower. Preliminary open interest rose 4,637 contracts. The weekly EIA report indicated that a r...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.